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BACKGROUND 
Following the serious failings in healthcare surrounding Poly Implant 
Prothèse breast implants, there is increased focus on the surveillance of 
medical devices, in particular surgical implants. This clinical epidemiology 
has historically been impeded by a lack of data on the procedures 
performed in insufficient linkage of those data to subsequent outcomes.  
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APPLICATION TO PROSTHETIC HEART VALVES 
The National Adult Cardiac Surgery Audit has collected data on all cardiac operations since 
the 1990s, including free-text information on prosthetic heart valve implants. Through 
development of algorithms to clean the registry and classify prosthesis models, and combine 
with clinical data to assess/monitor performance and trends. The graphs below show a 
simplified illustrated clinical example for 2 valve models – a mechanical and biological – 
from a working dataset of >95,000 aortic valve replacements and 100 model classifications. 
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Registry can be used to 
explore: 
•  clinical differences 
between 
characteristics 
•  short-term outcomes 
•  process based 
outcomes 
Temporal and spatial data 
can be used to explore 
equity of treatment access With record linkage, can 
monitor: 
•  long-term mortality 
•  readmission 
•  complications (stroke, 
MI, etc.) 
•  non-surgical re-
intervention 
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Log-rank test: P< 0.001
